These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 5158422)

  • 61. Ocular side effects of chloroquine in patients with rheumatoid arthritis, systemic lupus erythematosus and scleroderma.
    Leecharoen S; Wangkaew S; Louthrenoo W
    J Med Assoc Thai; 2007 Jan; 90(1):52-8. PubMed ID: 17621733
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The use of pentoxifylline in the treatment of systemic sclerosis and lipodermatosclerosis: a unifying hypothesis?
    Goldman MP
    J Am Acad Dermatol; 1994 Jul; 31(1):135-6. PubMed ID: 8054069
    [No Abstract]   [Full Text] [Related]  

  • 63. [Necrotizing circumscribed scleroderma after cupping therapy in arterial occlusion].
    Peter L
    Z Hautkr; 1986 Jul; 61(13):953-7. PubMed ID: 3751212
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Dimethyl sulfoxide in the treatment of scleroderma.
    Engel MF
    South Med J; 1972 Jan; 65(1):71-3. PubMed ID: 5058095
    [No Abstract]   [Full Text] [Related]  

  • 65. [Treatment of generalized (progressive) scleroderma].
    Balda BR
    Dtsch Med Wochenschr; 1972 Dec; 97(48):1876-8. PubMed ID: 4117979
    [No Abstract]   [Full Text] [Related]  

  • 66. Scleroderma and sclerotic skin conditions: unapproved treatments.
    Jablonska S; Blaszczyk M
    Clin Dermatol; 2002; 20(6):634-7. PubMed ID: 12490356
    [No Abstract]   [Full Text] [Related]  

  • 67. [Therapeutic effectiveness of carbon dioxide-hydrosulfide baths of Piatigorsk in complex therapy for children with scleroderma].
    Braĭtsev AV; Studnitsin AA; Nikitina MN; Kessel' VP; Marzeva GI
    Pediatriia; 1971 Nov; 50(11):30-2. PubMed ID: 4259038
    [No Abstract]   [Full Text] [Related]  

  • 68. [Endocrine changes in gestagen treatment in a patient with scleroderma diffusa].
    Krause W
    Hautarzt; 1980 Jan; 31(1):47-9. PubMed ID: 6446530
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Theoretical aspects of the new possibilities of use of hyaluronidase].
    Petter O; Bellmann H
    Z Gesamte Inn Med; 1971 Mar; 26(5):171-4. PubMed ID: 5560774
    [No Abstract]   [Full Text] [Related]  

  • 70. [So-called immunosuppressive cytotoxic medication in acute disseminated lupus erythematosus and scleroderma].
    Thivolet J; Perrot H
    Bull Soc Fr Dermatol Syphiligr; 1970; 77(3):412-4. PubMed ID: 5510738
    [No Abstract]   [Full Text] [Related]  

  • 71. Treatment of pediatric localized scleroderma with methotrexate.
    Fitch PG; Rettig P; Burnham JM; Finkel TH; Yan AC; Akin E; Cron RQ
    J Rheumatol; 2006 Mar; 33(3):609-14. PubMed ID: 16511930
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Reactive pathological changes of the parenchyma in collagenosis induced by beta-aminopropionitrile].
    Ifrim M; Papilian VV
    Verh Anat Ges; 1971; 66():329-33. PubMed ID: 4267391
    [No Abstract]   [Full Text] [Related]  

  • 73. A potential role for imatinib and other small molecule tyrosine kinase inhibitors in the treatment of systemic and localized sclerosis.
    Bibi Y; Gottlieb AB
    J Am Acad Dermatol; 2008 Oct; 59(4):654-8. PubMed ID: 18571768
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Familial linear scleroderma (en coup de sabre) responsive to antimalarials and narrowband ultraviolet B therapy.
    Brownell I; Soter NA; Franks AG
    Dermatol Online J; 2007 Jan; 13(1):11. PubMed ID: 17511944
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Symmetrical pigmented sclerosis enclosed by pruritic erythema: a new variant of morphoea?
    Minato H; Taki R; Miyachi Y; Utani A
    Br J Dermatol; 2009 Sep; 161(3):703-6. PubMed ID: 19575753
    [No Abstract]   [Full Text] [Related]  

  • 76. Guess what? Inflammatory disseminated morphea profunda.
    Savoia P; Zaccagna A; Bernengo MG
    Eur J Dermatol; 1999 Dec; 9(8):654-6. PubMed ID: 10651519
    [No Abstract]   [Full Text] [Related]  

  • 77. Guidelines of care for scleroderma and sclerodermoid disorders. American Academy of Dermatology.
    Drake LA; Dinehart SM; Farmer ER; Goltz RW; Graham GF; Hordinsky MK; Lewis CW; Pariser DM; Skouge JW; Webster SB; Whitaker DC; Butler B; Lowery BJ; Sontheimer RD; Callen JP; Camisa C; Provost TT; Tuffanelli DL
    J Am Acad Dermatol; 1996 Oct; 35(4):609-14. PubMed ID: 8859292
    [No Abstract]   [Full Text] [Related]  

  • 78. [Scleroderma in childhood].
    Becerril-Sánchez JF; Roldán-Labrada ME
    Bol Med Hosp Infant Mex; 1984 Oct; 41(10):556-60. PubMed ID: 6508897
    [No Abstract]   [Full Text] [Related]  

  • 79. Gestagen treatment of scleroderma.
    Holzmann H; Korting GW; Morsches B
    Australas J Dermatol; 1968 Jun; 9(3):237-40. PubMed ID: 5673929
    [No Abstract]   [Full Text] [Related]  

  • 80. Management of tolerance induction in patients with suspected penicillin allergy--a case study.
    Wessbecher R; Stangl S
    Int J Dermatol; 2009 May; 48(5):488-91. PubMed ID: 19416379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.